When designing a therapy, how the drug will reach the area of the disease is an important matter. To treat a bruise on our skin we can use a gel to reduce the pain and swelling locally. If we had a headache though, we would need to bring the drug inside the body somehow. For example, an aspirin goes through … Read More
New Deal at #UEGweek 2019
The United European Gastroenterology (UEG) week is taking place from the 19th to the 23rd October in Barcelona, and the New Deal project team will attend it! We will hold a Common Interest Group meeting called “Unmet therapeutic needs in IBD – how new targeted medicine could help” the 22nd of October at 18:00h. Recent therapeutic development programs in the … Read More
October New Deal Reads
1. Nanocarrier-based systems for targeted and site specific therapeutic delivery. Majumber et al. 2019. Advanced Drug Delivery Reviews. One of the major problems of the current IBD therapies is that they produce side effects when they are delivered in a systemic way like oral administration. Thus, there is a need to develop targeted delivery strategies that affect only the body … Read More
New Deal News: Team meeting in Vigo
During our stay in Vigo, we had the chance to review the advances of the past six months going over our the most important results from all our partners and troubleshooting critical points. We also had time to discuss our global progress and together define the next steps that will be key for the success of the project. As closure … Read More
